ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Oculis Strengthens Leading Ophthalmology Pipeline by In-Licensing Neuroprotective Drug Candidate for Glaucoma from Accure Therapeutics
March 08, 2022Oculis S.A., (Oculis) a global ophthalmology company developing life-changing treatments to save sight and improve eye care with breakthrough innovations, and Accure Therapeutics, a private translational neuroscience R&D company... -
AGC Biologics and Oculis Enter Manufacturing Deal
May 08, 2021AGC Biologics, a global biopharmaceutical contract development and manufacturing organization (CDMO), has entered a partnership with Oculis to manufacture OCS-02, a Phase II investigational drug targeting both Dry Eye Disease and Anterior Uveitis ... -
Oculis Reports Positive Data from OCS-01 Trial for Cataract Surgery Pain, Inflammation
May 28, 2020Oculis has reported positive results from its Phase 2 SKYGGN study of OCS-01. -
Swiss biotech Oculis raises cash, nabs Novartis eye drug in extended series B
January 07, 2019Hoping to push on with its work on next-gen eye treatments, Oculis has raised an extra CHF 15 million ($15.2 million) as it looks to fellow native Swiss biopharma Novartis for its next project....
Pharma Sources Insight January 2025
